Axon hits session-low 15%, most since November, after earnings

Axon Enterprise (AXON) shares fell to a session low of 15% following the release of its Q2 2026 earnings report on August 5, marking the largest single-day decline since November 2025. The stock closed at $525.12, down 1.14% for the day, underperforming broader market indices such as the S&P 500, which gained 1.66%. The decline came despite revenue growth that exceeded expectations, with the Zacks Consensus Estimate projecting net sales of $868.35 million, a 29.89% increase year-over-year. However, earnings per share are expected to decline by 10.85% to $1.89.

The stock has declined by 10.57% over the past month, outpacing the 2.26% loss in the Aerospace sector and the 1.49% loss in the S&P 500. Analysts had anticipated a strong earnings report to sustain the upward momentum seen earlier in the week, but the post-earnings reaction suggests mixed sentiment. Axon’s Forward P/E ratio of 67.84 remains elevated compared to the industry average of 35.85, and its PEG ratio of 2.25 indicates that the stock is trading at a premium relative to its projected earnings growth.

The company has demonstrated consistent growth in recent years, with 2022 revenue reaching $1.19 billion, driven by a 38% year-over-year increase and strong performance in its Axon Cloud software suite. In Q1 2023, Axon reported revenue of $343 million, up 34% year-over-year, with Axon Cloud revenue growing by 51%. Despite these positive trends, the recent earnings-driven selloff highlights investor caution ahead of the company’s 2025 revenue target of $2 billion.

The Zacks Rank for Axon remains at #3 (Hold), reflecting stagnant revisions to analyst estimates in the past 30 days. Investors will be watching closely for signs of stabilization or further volatility as the company continues to navigate its expansion into new markets and product innovations such as the TASER 10 and Axon Body 4Axon Body 4 innovations.